CS logo
small CS logo
IRCCS S. Raffaele; Ginecologia Oncologica

Milano, Lombardia, Italy

About IRCCS S. Raffaele; Ginecologia Oncologica


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at IRCCS S. Raffaele; Ginecologia Oncologica


During the past decade, IRCCS S. Raffaele; Ginecologia Oncologica conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "IRCCS S. Raffaele; Ginecologia Oncologica" #1 collaborator was "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator and "GOG Foundation" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at IRCCS S. Raffaele; Ginecologia Oncologica


According to Clinical.Site data, the most researched conditions in "IRCCS S. Raffaele; Ginecologia Oncologica" are "Ovarian Cancer" (2 trials), "Cervical Cancer" (1 trials), "Fallopian Tube Cancer" (1 trials) and "Peritoneal Neoplasms" (1 trials). Many other conditions were trialed in "IRCCS S. Raffaele; Ginecologia Oncologica" in a lesser frequency.

Clinical Trials Intervention Types at IRCCS S. Raffaele; Ginecologia Oncologica


Most popular intervention types in "IRCCS S. Raffaele; Ginecologia Oncologica" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Bevacizumab" (2 trials), "Paclitaxel" (2 trials), "Abemaciclib" (1 trials) and "Atezolizumab Placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at IRCCS S. Raffaele; Ginecologia Oncologica


The vast majority of trials in "IRCCS S. Raffaele; Ginecologia Oncologica" are 3 trials for "Female" genders.

Clinical Trials Status at IRCCS S. Raffaele; Ginecologia Oncologica


Currently, there are NaN active trials in "IRCCS S. Raffaele; Ginecologia Oncologica". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in IRCCS S. Raffaele; Ginecologia Oncologica, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in IRCCS S. Raffaele; Ginecologia Oncologica, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".